This paper describes the lead optimization of a new series of potent, selective, orally bioavailable, brain-penetrant MCH-1 receptor antagonists. A major focus of the work was to achieve a selectivity profile appropriate for in vivo efficacy studies and safety.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2008.01.010DOI Listing

Publication Analysis

Top Keywords

potent selective
8
mch-1 receptor
8
receptor antagonists
8
selective mch-1
4
antagonists paper
4
paper describes
4
describes lead
4
lead optimization
4
optimization series
4
series potent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!